We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$438M
AUM Growth
+$25.1M
Cap. Flow
+$13.6M
Cap. Flow %
3.1%
Top 10 Hldgs %
21.07%
Holding
312
New
80
Increased
50
Reduced
26
Closed
102

Top Buys

Rank Stock Value
1
AEM icon
Agnico Eagle Mines
AEM
+$8.29M
2
IDCC icon
InterDigital
IDCC
+$4.45M
3
CTSH icon
Cognizant
CTSH
+$4.02M
4
GL icon
Globe Life
GL
+$3.82M
5
G icon
Genpact
G
+$3.8M

Sector Composition

Rank Sector Weight
1 Healthcare 22.59%
2 Technology 17.67%
3 Materials 16.79%
4 Financials 11.81%
5 Consumer Staples 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAM icon
26
EPAM Systems
EPAM
$5.51B
$3.71M 0.85%
+21,000
New +$3.51M
G icon
27
Genpact
G
$5.96B
$3.7M 0.84%
+84,000
New +$3.8M
NVO
28
Novo Nordisk
NVO
$208B
$3.62M 0.83%
52,500
-10,500
-17% -$714K
ALKS icon
29
Alkermes
ALKS
$8.22B
$3.6M 0.82%
+126,000
New +$3.75M
DOLE icon
30
Dole
DOLE
$1.35B
$3.53M 0.81%
252,000
+105,000
+71% +$1.49M
NCLH icon
31
Norwegian Cruise Line
NCLH
$8.51B
$3.41M 0.78%
+168,000
New +$3.01M
AGI icon
32
Alamos Gold
AGI
$11.6B
$3.39M 0.77%
127,500
+117,300
+1,150% +$3.14M
PEP icon
33
PepsiCo
PEP
$190B
$3.33M 0.76%
25,200
HRMY icon
34
Harmony Biosciences
HRMY
$2.04B
$3.32M 0.76%
105,000
+21,000
+25% +$676K
WAL icon
35
Western Alliance Bancorporation
WAL
$8.79B
$3.28M 0.75%
42,000
+21,000
+100% +$1.51M
DOCU
36
DocuSign
DOCU
$10.5B
$3.27M 0.75%
+42,000
New +$3.4M
GIS icon
37
General Mills
GIS
$19.1B
$3.26M 0.75%
63,000
MTB icon
38
M&T Bank
MTB
$35.7B
$3.26M 0.74%
16,800
+2,100
+14% +$371K
DOCS icon
39
Doximity
DOCS
$3.81B
$3.22M 0.74%
+52,500
New +$2.93M
CPRX
40
DELISTED
Catalyst Pharmaceutical
CPRX
$3.19M 0.73%
147,000
+63,000
+75% +$1.49M
KGC icon
41
Kinross Gold
KGC
$27.4B
$3.19M 0.73%
204,000
-102,000
-33% -$1.48M
APPN icon
42
Appian
APPN
$1.98B
$3.14M 0.72%
+105,000
New +$3.15M
ASTH icon
43
Astrana Health
ASTH
$1.76B
$3.13M 0.72%
126,000
+42,000
+50% +$1.18M
CORT icon
44
Corcept Therapeutics
CORT
$12.4B
$3.08M 0.7%
42,000
PTCT icon
45
PTC Therapeutics
PTCT
$5.68B
$3.08M 0.7%
63,000
+42,000
+200% +$1.99M
CCOI icon
46
Cogent Communications
CCOI
$676M
$3.04M 0.69%
63,000
+42,000
+200% +$2.13M
AUPH icon
47
Aurinia Pharmaceuticals
AUPH
$1.91B
$3.02M 0.69%
357,000
+147,000
+70% +$1.18M
MD icon
48
Pediatrix Medical
MD
$2.18B
$3.01M 0.69%
210,000
+126,000
+150% +$1.73M
BFH icon
49
Bread Financial
BFH
$4.37B
$3M 0.69%
52,500
+21,000
+67% +$1.06M
LULU icon
50
lululemon athletica
LULU
$13.5B
$2.99M 0.68%
+12,600
New +$3.47M

Similar funds

Hussman Strategic Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Hussman Strategic Advisors held 312 positions worth $438M, up 6.1% from $413M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Hussman Strategic Advisors deployed $13.6M of net new capital in Q2 2025, opening 80 new positions and adding to 50 existing holdings. Its largest new stake was InterDigital: 21,000 shares worth $4.71M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was AngloGold Ashanti, an estimated $4.39M trimmed.

  • Hussman Strategic Advisors's largest Q2 2025 buy was InterDigital: 21,000 shares worth $4.71M.
  • Hussman Strategic Advisors added most to Agnico Eagle Mines in Q2 2025, an estimated $8.29M increase.
  • Hussman Strategic Advisors's biggest Q2 2025 reduction was AngloGold Ashanti, cutting an estimated $4.39M.
  • Hussman Strategic Advisors fully exited Alphabet (Google) Class C in Q2 2025, selling an estimated $4.92M.
  • Hussman Strategic Advisors's ten largest holdings make up 21% of its $438M portfolio in Q2 2025.
  • Hussman Strategic Advisors opened 80 new positions and closed 102 in Q2 2025.
  • Hussman Strategic Advisors's portfolio value rose 6.1% quarter-over-quarter to $438M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.